Dey Sougata, Schepmann Dirk, Wünsch Bernhard
Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraße 48, D-48149 Münster, Germany; NRW Graduate School of Chemistry, Westfälischen Wilhelms-Universität Münster, Wilhelm-Klemm-Str. 10, D-48149 Münster, Germany.
Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.
Bioorg Med Chem. 2018 Jan 15;26(2):501-508. doi: 10.1016/j.bmc.2017.12.010. Epub 2017 Dec 7.
The NMDA receptor containing GluN2B subunits represents a promising target for the development of drugs for the treatment of various neurological disorders including neurodegenerative diseases. In order to study the role of CH and OH moieties trisubstituted tetrahydro-3-benzazepines 4 were designed as missing link between tetra- and disubstituted 3-benzazepines 2 and 5. The synthesis of 4 comprises eight reaction steps starting from alanine. The intramolecular Friedel-Crafts acylation to obtain the ketone 12 and the base-catalyzed elimination of trifluoromethanesulfinate (CFSO) followed by NaBH reduction represent the key steps. The GluN2B affinity of the cis-configured 3-benzazepin-1-ol cis-4a with a 4-phenylbutyl side chain (K = 252 nM) is considerably lower than the GluN2B affinity of (R,R)-2 (K = 17 nM) indicating the importance of the phenolic OH moiety for the interaction with the receptor protein. Introduction of an additional CH moiety in 2-position led to a slight decrease of GluN2B affinity as can be seen by comparing the affinity data of cis-4a and 5. The homologous phenylpentyl derivative cis-4b shows the highest GluN2B affinity (K = 56 nM) of this series of compounds. According to docking studies cis-4a adopts the same binding mode as the cocrystallized ligand ifenprodil-keto 1A and 5 at the interface of the GluN2B and GluN1a subunits. The same crucial H-bonds are formed between the C(O)NH moiety of Gln110 within the GluN2B subunit and the protonated amino moiety and the OH moiety of (R,R)-cis-4a.
含有GluN2B亚基的N-甲基-D-天冬氨酸受体是开发用于治疗包括神经退行性疾病在内的各种神经疾病药物的一个有前景的靶点。为了研究CH和OH基团的作用,设计了三取代四氢-3-苯并氮杂䓬4作为四取代和二取代3-苯并氮杂䓬2和5之间的缺失环节。4的合成从丙氨酸开始包括八个反应步骤。通过分子内傅克酰基化反应得到酮12,然后进行碱催化的三氟甲磺酸盐(CFSO)消除反应,接着用硼氢化钠还原,这些是关键步骤。具有4-苯基丁基侧链的顺式构型3-苯并氮杂䓬-1-醇顺式-4a对GluN2B的亲和力(K = 252 nM)明显低于(R,R)-2对GluN2B的亲和力(K = 17 nM),这表明酚羟基部分对于与受体蛋白相互作用的重要性。通过比较顺式-4a和5的亲和力数据可以看出,在2-位引入额外的CH基团会导致GluN2B亲和力略有下降。同源的苯基戊基衍生物顺式-4b在这一系列化合物中显示出最高的GluN2B亲和力(K = 56 nM)。根据对接研究,顺式-4a在GluN2B和GluN1a亚基的界面处采用与共结晶配体艾芬地尔-酮1A和5相同的结合模式。在GluN2B亚基内的Gln110的C(O)NH部分与(R,R)-顺式-4a的质子化氨基部分和OH部分之间形成了相同的关键氢键。